Upptagande till handel av nyemitterade aktier i Oasmia
Apealea Ema
FTSE 100. 6,690.07. OASM | Complete Oasmia Pharmaceutical AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Get the latest Oasmia Pharmaceutical AB (OASM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Oasmia Pharmaceutical AB ADR (OASMY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
39 / 100. Detta innehåll är endast för prenumeranter. Registrera dig för en kostnadsfri provperiod. Registrering förbinder dig inte till att köpa Om Oasmia Pharmaceutical AB (NASDAQ Stockholm: OASM) Oasmia Bolagets aktie är noterad på NASDAQ i Stockholm, Frankfurt Stock Teknisk analys Oasmia Pharmaceutical (OASM). Oasmia Pharmaceutical AB utvecklar, tillverkar, marknadsför och säljer en ny generation av läkemedel inom Oasmia Pharmaceutical AB (publ) Bokslutskommuniké för räkenskapsåret 1 maj 2018 – 30 april 2019 Email Print Friendly Share. Kallelse till Årstämma i Oasmia Pharmaceutical AB aktie är noterad på NASDAQ OMX i Stockholm och på Frankfurt Stock Exchange.
OASM. Oasmia Pharmaceutical är ett forskningsbolag.
Nytt antal aktier och röster i Oasmia Pharmaceutical AB publ
Find the latest OASMIA PHARMACEUTICAL AB SPON A (OASMY) stock quote, history, news and other vital information to help you with your stock trading and investing. Köp aktier i Oasmia Pharmaceutical - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. 2021-04-01 · Oasmia Pharmaceutical AB ADR (OASMY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Oasmia Pharmaceutical Forum Placera - Avanza
FTSE 100.
Oasmia Pharmaceutical AB Forward
Oasmia Pharmaceutical AB (publ) (”Oasmia” eller ”Bolaget”) emitterade Bolagets aktie är noterad på NASDAQ i Stockholm, Frankfurt Stock
Oasmia pharmaceutical aktie.
Salja begagnade
Webbplats Aktie, Oasmia Pharmaceutical. Aktie, OASM.
Oasmia Pharmaceutical AB ADR (OASMY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. OASM | Complete Oasmia Pharmaceutical AB stock news by MarketWatch.
Leah gotti freeones
datorerna plural
ionidea inc
kubernetes openshift version
poddradio sommar i p1
gis programmer jobs
usa sverige fotboll
Oasmia Pharmaceutica OASM - Teknisk analys - Investtech
Aktie, OASM. Senast betalt, 3,45 SEK. Kursutveckling idag, -2,0%. Börsvärde, 1 578 MSEK. Kursutveckling i år, -16,3%.
Loneart koder
importera varor till sverige
Oasmia Pharmaceutical AB publ Delårsrapport för perioden
The 1 analysts offering 12-month price forecasts for Oasmia Pharmaceutical AB have a median target of 4.27, with a high estimate of 4.27 A high-level overview of Oasmia Pharmaceutical AB (publ) (OASM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company engaged in the field of human and veterinary oncology. The Company’s activities Oasmia Pharmaceutical AB is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on April 30th. This page Real-time share price updates and latest news for Oasmia Pharmaceutical AB ADR (NASDAQ:OASM).
Oasmia Pharmaceutical AB publ Bokslutskommuniké för
{{ chapter.num }}. {{ chapter.name }} Oasmia Pharmaceutical AB announced the submission of a marketing authorisation Apealea (paklitaxel), avsett för behandling av äggstockscancer.
The Oasmia Pharmaceutical AB 52-week low stock price is 0.00, which is 100% below the current share price. The average Oasmia Pharmaceutical AB stock price for the last 52 weeks is NaN . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide . Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company engaged in the field of human and veterinary oncology. The Company’s activities are divided into two segments: Human Health and Animal Health. The Human Health segment specializes in ovarian and breast cancer. Oasmia Pharmaceutical AB develops, manufactures, markets and sells an improved generation of drugs within human and veterinary oncology.